Skip to main content

Table 1 Baseline characteristics of study participants

From: Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service – results from the prospective, multi-center, observational cohort study thrombEVAL

Characteristic Regular medical care Coagulation service
Subjects 2,011 760
Male sex, % (no.) 62.2 (1,251) 52.0 (395)
Age, years 73.0 (66.0/79.0) 73.0 (63.0/80.0)
Body mass index, kg/m2 27.6 (24.7/31.1) 27.8 (24.9/31.2)
Classical cardiovascular risk factors   
Diabetes, % (no.) 30.8 (617) 26.0 (196)
Dyslipidemia, % (no.) 51.9 (1,043) 42.0 (319)
Family history of MI and/or stroke/TIA, % (no.) 38.2 (768) 30.4 (231)
Hypertension, % (no.) 79.1 (1,590) 75.7 (575)
Obesity, % (no.) 30.6 (616) 31.6 (240)
Smoking, % (no.) 6.7 (135) 5.5 (42)
Concomitant diseases   
Atrial fibrillation, % (no.) 72.7 (1,452) 63.6 (483)
Autoimmune disease, % (no.) 8.6 (170) 7.4 (56)
Chronic kidney disease, % (no.) 22.4 (447) 15.8 (120)
Chronic obstructive pulmonary disease, % (no.) 21.0 (417) 15.6 (118)
Coronary artery disease, % (no.) 39.9 (773) 27.8 (210)
Depression, % (no.) 8.8 (176) 7.7 (58)
Heart failure, % (no.) 41.2 (813) 30.5 (230)
Liver disease, % (no.) 5.6 (112) 3.4 (26)
Myocardial infarction, % (no.) 20.0 (400) 12.2 (92)
Neoplasm, % (no.) 17.8 (354) 19.0 (142)
Peripheral artery disease, % (no.) 20.7 (408) 11.1 (84)
Sleep apnea, % (no.) 9.7 (186) 7.8 (58)
Stroke or TIA, % (no.) 17.3 (348) 17.5 (133)
  1. Data are expressed as the relative and absolute frequencies for binary variables, for normally distributed variables as median with 25th/75th percentile. Double entries are possible for study participants in the coagulation service cohort with prior treatment in regular medical care. TIA, Transient ischemic attack; MI, Myocardial infarction. Significant difference between the groups (P <0.05) was detected for hypertension, dyslipidemia, family history of MI/stroke/TIA, coronary artery disease, myocardial infarction, heart failure, peripheral artery disease, atrial fibrillation, chronic kidney disease, and liver disease.